CLINICAL_TRIALS
trial_result
· 2009-10-23
Clinical Trial Update: Sitagliptin Added-on to Insulin Study (0431-051) [Phase 3]
Summary
A Phase 3 study evaluating sitagliptin added to insulin in Type 2 diabetes completed with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2009-10-23